Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug;113(8):2704-13.
doi: 10.1002/jcb.24148.

Acetylcholine induces mesenchymal stem cell migration via Ca2+ /PKC/ERK1/2 signal pathway

Affiliations

Acetylcholine induces mesenchymal stem cell migration via Ca2+ /PKC/ERK1/2 signal pathway

Jun-Ming Tang et al. J Cell Biochem. 2012 Aug.

Abstract

Acetylcholine (ACh) plays an important role in neural and non-neural function, but its role in mesenchymal stem cell (MSC) migration remains to be determined. In the present study, we have found that ACh induces MSC migration via muscarinic acetylcholine receptors (mAChRs). Among several mAChRs, MSCs express mAChR subtype 1 (m1AChR). ACh induces MSC migration via interaction with mAChR1. MEK1/2 inhibitor PD98059 blocks ERK1/2 phosphorylation while partially inhibiting the ACh-induced MSC migration. InsP3Rs inhibitor 2-APB that inhibits MAPK/ERK phosphorylation completely blocks ACh-mediated MSC migration. Interestingly, intracellular Ca(2+) ATPase-specific inhibitor thapsigargin also completely blocks ACh-induced MSC migration through the depletion of intracellular Ca(2+) storage. PKCα or PKCβ inhibitor or their siRNAs only partially inhibit ACh-induced MSC migration, but PKC-ζ siRNA completely inhibits ACh-induced MSC migration via blocking ERK1/2 phosphorylation. These results indicate that ACh induces MSC migration via Ca(2+), PKC, and ERK1/2 signal pathways.

PubMed Disclaimer

Figures

Fig 1
Fig 1. MSC phenotype characterization
Flow cytometric analysis showed that MSC expressed CD34 (0.74%) (A), CD45 (0.19%) (B), CD90 (92%) (B), and CD29 (91%) (D). (E–F) MSC differentiation in special culture conditions in vitro. (E) Osteocyte differentiation as shown by von Kossa staining. (F) Adipogenic differentiation as shown by Oil-O-Red staining.
Fig 2
Fig 2. mAChR expression in MSC
(A) m1AChR mRNA expression in MSC was detected by RT-PCR. (B) m1AChR expression was detected by immunostaining of MSC. (C) Flow cytometric analysis of m1AChR expression in MSCs. (D) L-Ca2+ channel, N-Ca2+ channel, and InsP3Rs expression in MSC was detected by RT-PCR. (E) RYRs expression in MSC was detected by RT-PCR.
Fig 3
Fig 3. The effect of ACh on MSC proliferation and migration
(A, B) ACh had no effect on MSC proliferation, * p>0.05 vs Ctrl. (C) Ach induced MSC migration in a dose-dependent manner, * p<0.05 vs Ctrl. (D) ACh induced MSC migration in a time-dependent manner, * p<0.05 vs Ctrl in 12 h, # p<0.05 vs Ctrl in 24 h. (E). ACh-induced MSC migration was inhibited by atropine, a mAChR blocker, # p<0.05 vs ACh (10−6 M).
Fig 4
Fig 4. MSC migration determined by wound healing assay
(A) 2×105 cells were seeded into 24-well plates coated with 10 mg/ml fibronectin. Monolayer cell wounds were produced by CytoSelect insert. 10−5~10−9 M of ACh was added to 15% FCS-containing DMEM. MSC migration was photographed at the times indicated. * p<0.05 vs ACh (0, 10−7, 10−8, or, 10−9 M). # p<0.05 vs ACh (10−6 M). (B) MSCs were treated with ACh (10−6 M) for 0, 6, 12, and 24 h, and scrape wound healing assays were performed as described in A. * p<0.05 vs Ctrl in 6 h, & p<0.05 vs Ctrl in 12 h, # p<0.05 vs Ctrl in 24 h. (C) MSCs were treated with ACh (10−6M) with or without atropine treatment (10−4 M) for 12 h. Scrape wound healing assays were performed. *p<0.05. vs. ACh (10−6 M).
Fig 5
Fig 5. ACh promoted MSC migration via activation of ERK1/2
(A) ACh Activated ERK1/2 via mAChR. Upper panel: western blot detection of ERK1/2 phosphorylation (pERK1/2) and ERK1/2 expression. α-tubulin served as an internal control. Lower panel: Quantification of phosphorylated ERK1/2. *, #P<0.05 vs ACh (10−6 M) (n=5). (B) ERK1/2 is essential for ACh-induced MSC migration. *p<0.05 vs ACh (10−6 M), n=5.
Fig 6
Fig 6. ACh promoted MSC migration via activation of PKC signaling
(A) ACh Activated PKCα via mAChR. PKC phosphorylation and expression were determined by western blot. α-tubulin served as an internal control. (B) Quantification of phosphorylated PKCα. *, # P < 0.05 vs ACh (10−6 M), n=5. (C) PKCα/PKCβ selective inhibitor Gö-6976 (6 nM) blocked ACh-induced MSC migration. *, # P<0.05 vs ACh, n=5. (D) siRNA blockade of PKCα, PKCβ, or PKCζ inhibited ACh-induced MSC migration. *, #, & P<0.05 vs ACh (10−6 M), n=5.
Fig 7
Fig 7. Role of Calcium in ACh-induced MSC migration and PKC and ERK1/2 phosphorylation
(A) Extracellular Ca2+ in ACh-induced MSC migration, *P<0.05 vs PBS; #P<0.05 vs PBS+ACh. (B) ACh-induced MSC migration required Ca2+ release mediated by InsP3Rs. *P> 0.05 vs ACh (10−6 M); #, &, $, @P<0.05 vs ACh (10−6 M). (C–D) Role of Calcium in ACh-induced PKC and ERK1/2 phosphorylation. Upper panel: phosphorylated and total PKC (C) or ERK1/2 (D) was detected by western blot. α-tubulin served as an internal control. Lower panel: Quantification of phosphorylated PKC or ERK1/2. *, #P<0.05 vs ACh (10−6 M), n=5.
Fig 8
Fig 8. Role of PKC in ACh-induced ERK1/2 phosphorylation
(A–D) Western blot of ERK1/2 phosphorylation (pERK1/2) and expression (tERK1/2), α-tubulin served as an internal control. *, #, &P < 0.05 vs ACh (10−6 M). in each panel, n = 5.

Similar articles

Cited by

References

    1. Agell N, Bachs O, Rocamora N, Villalonga P. Modulation of the Ras/Raf/MEK/ERK pathway by Ca(2+), and calmodulin. Cell Signal. 2002;14:649–654. - PubMed
    1. Bobis S, Jarocha D, Majka M. Mesenchymal stem cells: characteristics and clinical applications. Folia Histochem Cytobiol. 2006;44:215–30. - PubMed
    1. Boland GM, Perkins G, Hall DJ, Tuan RS. Wnt3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem. 2004;93:1210–1230. - PubMed
    1. Boss A, Oppitz M, Lippert G, Drews U. Muscarinic cholinergic receptors in the human melanoma cell line SK-Mel 28: modulation of chemotaxis. Clin Exp Dermatol. 2005;30:557–64. - PubMed
    1. Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem. 1994;56:283–94. - PMC - PubMed

Publication types

LinkOut - more resources